Cancer Diagnostics Market

Cancer Diagnostics Market

Cancer Diagnostics Market: Biopsy Test Type Segment Expected to Remain Dominant Throughout the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016 - 2026

  • XPLREP805

  • May, 2017

  • 207 Pages

  • Cancer

Escalating fatalities due to Cancer Driving the Cancer Diagnostics Market

As per a report published on XploreMR, the global cancer diagnostics market is expected to grow two-fold in the years to come.

The ever-increasing incidences of oncologic cases, technological upgradations in diagnostics on the continuous basis, and growing demand for proper screening tests are amongst the prime factors driving the cancer diagnostics market across the globe. Governments around the world are also supporting cancer diagnostics-related initiatives, which acts as another booster to the market.

It is a well-known fact that cancer accounts for a major portion of fatalities all across. As such, the healthcare personnel are emphasizing on developing proper diagnostic as well as treatment solutions for checking the level of prevalence. The fact that detection at early stages results in increase in success rates of the treatment regimens also calls for spurt in cancer diagnostics.

Biopsy is expected to remain the most lucrative cancer diagnostics test due to technological advancements such as fine needle aspiration

The biopsy test type segment dominated the global cancer diagnostics market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. Biopsy is the largest segment, which was valued at more than US$ 11 Bn in 2016 and is expected to expand at a CAGR of 7.4% over the forecast period. The liquid biopsy test type segment is expected to register fastest Y-o-Y growth throughout the forecast period. Even though liquid biopsy is becoming more popular due to its non-invasive nature, to obtain an accurate diagnosis, solid tumour biopsies or tissue biopsies are still preferred.

Despite the headwinds of regulatory uncertainties, diagnostic companies continue to invest in high dollar molecular diagnostic tests for cancer research

To purchase test reagents, a majority of diagnostic companies place these instruments in diagnostic and research laboratories through reagent rental contracts in exchange for long-term contracts, as tests can only be run in laboratories possessing instruments for which the test is developed and approved. Moreover, newly developed tests for particular instruments need to be mass marketed to diagnostic laboratories, general practitioners, and health insurers.

Purchase Options
Cancer Diagnostics Market: Biopsy Test Type Segment Expected to Remain Dominant Throughout the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016 - 2026
Buy Now
Custom Market Research Services

Custom Market Research Services

xploreMR offers custom market reserch services that help clients to get information on their business scenario required where syndicated solutions are not enough

Why Choose XploreMR

Why Choose XploreMR
  • Analyst Support

    Our analysts go above and beyond to answer your specific queries. We are with you throughout the entire journey – from initial discussion to post-purchase.

  • Country-wise Analysis & Forecasting

    As we track markets at country-level, we are able to offer hard-to-find market intelligence in both developed and emerging countries.

  • High Quality At Competitive Pricing

    We believe high quality market research shouldn’t be out of reach for businesses. Our competitively-priced market research reports ensure businesses of all sizes have access to quality information

Popular Reports

Cancer Biomarkers Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Cancer Biomarkers Market- Scope of the Report The recent study by XploreMR on cancer biomarkers market offers a 5-year forecast between 2020 and 2025. The study analyzes crucial trends that ...

Global Market Study on Bile Duct Cancer (Cholangiocarcinoma) Treatment: North America & Europe to Hold over ~30% Market Share During 2017-2025

Report Introduction The report ‘Bile Duct Cancer (Cholangiocarcinoma) Treatment Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)’ is a comprehensive compilation ...